These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10294)

  • 1. Differences in phosphofructokinase regulation in normal and tumor rat thyroid cells.
    Meldolesi MF; Macchia V; Laccetti P
    J Biol Chem; 1976 Oct; 251(20):6244-51. PubMed ID: 10294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rat thyroid phosphofructokinase. Comparison of the regulatory and molecular properties with those of rat muscle enzyme.
    Meldolesi MF; Laccetti P
    J Biol Chem; 1979 Sep; 254(18):9200-3. PubMed ID: 158021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isozymic composition and regulatory properties of phosphofructokinase from well-differentiated and anaplastic medullary thyroid carcinomas of the rat.
    Oskam R; Rijksen G; Staal GE; Vora S
    Cancer Res; 1985 Jan; 45(1):135-42. PubMed ID: 3155492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of phosphofructokinase from rat skeletal muscle. Effects of fructose diphosphate, AMP, ATP, and citrate.
    Tornheim K; Lowenstein JM
    J Biol Chem; 1976 Dec; 251(23):7322-8. PubMed ID: 12161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the allosteric properties of pure low and high phosphate forms of phosphofructokinase from rat liver.
    Sakakibara R; Uyeda K
    J Biol Chem; 1983 Jul; 258(14):8656-62. PubMed ID: 6223034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphofructokinase in normal thyroid tissue and thyroid neoplasms.
    van der Heijden MC; Verhagen JN; Rijksen G; der Kinderen PJ; van Unnik JA; Staal GE
    Tumour Biol; 1986; 7(1):9-18. PubMed ID: 2944210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart phosphofructokinase: allosteric kinetics with fructose 6-sulfate.
    Martensen TM; Mansour TE
    Biochemistry; 1976 Nov; 15(23):4973-80. PubMed ID: 136271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric properties of rat lung phosphofructokinase.
    Tejwani GA; Mousa S
    Enzyme; 1981; 26(6):306-14. PubMed ID: 6273150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some properties of phosphofructokinase from kidney cortex and their relation to glucose metabolism.
    Underwood AH; Newsholme EA
    Biochem J; 1967 Jul; 104(1):296-9. PubMed ID: 4226812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial purification and regulatory properties of phosphofructokinase from Aspergillus niger.
    Habison A; Kubicek CP; Röhr M
    Biochem J; 1983 Mar; 209(3):669-76. PubMed ID: 6223622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric properties of phosphofructokinase from the epithelial cells of thermally injured rat small intestine.
    Khoja SM; Salleh M; Ardawi M
    Comp Biochem Physiol B; 1987; 87(3):469-72. PubMed ID: 2957148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The control of rat-heart phosphofructokinase by citrate and other regulators.
    Pogson CI; Randle PJ
    Biochem J; 1966 Sep; 100(3):683-93. PubMed ID: 4291039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and properties of adductor muscle phosphofructokinase from the oyster, Crassostrea virginica. The aerobic/anaerobic transition: role of arginine phosphate in enzyme control.
    Storey KB
    Eur J Biochem; 1976 Nov; 70(2):331-7. PubMed ID: 12948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of muscle phosphofructokinase at physiological concentration of enzyme.
    Boscá L; Aragón JJ; Sols A
    J Biol Chem; 1985 Feb; 260(4):2100-7. PubMed ID: 2982809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the Embden-Meyerhof pathway in a transplantable rat thyroid tumor.
    Meldolesi MF; Macchia V
    Cancer Res; 1972 Dec; 32(12):2793-8. PubMed ID: 4345406
    [No Abstract]   [Full Text] [Related]  

  • 16. Activation of muscle phosphofructokinase by alpha-glucose 1,6-bisphosphate and fructose 2,6-bisphosphate is differently affected by other allosteric effectors and by pH.
    Andrés V; Carreras J; Cussó R
    Biochem Biophys Res Commun; 1988 Dec; 157(2):664-9. PubMed ID: 2974284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desensitization of muscle phosphofructokinase to ATP inhibition by removal of a carboxyl-terminal heptadecapeptide.
    Valaitis AP; Foe LG; Kemp RG
    J Biol Chem; 1987 Apr; 262(11):5044-8. PubMed ID: 2951376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic behaviour and regulatory properties of phosphofructokinase in rat bone marrow cells.
    Tejedor MC; Ramírez A; Luque J
    Biochem Int; 1984 Nov; 9(5):577-86. PubMed ID: 6098275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Properties of erythrocyte phosphofructokinase in normal humans].
    Mandereau J; Boivin P
    Biochimie; 1973; 55(11):1341-51. PubMed ID: 4364375
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulation of adult and fetal myocardial phosphofructokinase. Relief of cooperativity and competition between fructose 2,6-bisphosphate, ATP, and citrate.
    Bristow J; Bier DM; Lange LG
    J Biol Chem; 1987 Feb; 262(5):2171-5. PubMed ID: 2950086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.